Ignite Creation Date:
2024-05-05 @ 7:40 PM
Last Modification Date:
2024-10-26 @ 9:52 AM
Study NCT ID:
NCT00716924
Status:
COMPLETED
Last Update Posted:
2009-09-25
First Post:
2008-07-15
Brief Title:
CASTLE Clopidogrel And Serum Troponin Level Elevation
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Clopidogrel 600 mg and 300 mg as a Loading Dose Prior to Percutaneous Coronary Intervention And Serum Troponin Level Elevation A Pilot Study
Status:
COMPLETED
Status Verified Date:
2009-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CASTLE
Brief Summary:
Primary Objective To test if 600 mg of clopidogrel loading dose administered 6 and 24 hours prior to PCI produce a greater decrease of periprocedural release of biochemical markers CK CK-MB and troponin-T andor I of myocardial necrosis compared to 300 mg loading dose given 6 and 24 hours prior to PCI or 600 mg loading dose of clopidogrel administered immediately 45 minutes before PCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None